CLOSATAK CLOSANTEL SUSTAINED ACTION ORAL ANTHELMINTIC AND FLUKICIDE FOR SHEEP AND LAMBS Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

closatak closantel sustained action oral anthelmintic and flukicide for sheep and lambs

abbey laboratories pty ltd - closantel - oral solution/suspension - closantel anthelmintic active 37.5 g/l - parasiticides

CLOZARIL- clozapine tablet Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

clozaril- clozapine tablet

tya pharmaceuticals - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozaril is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the significant risk of agranulocytosis and seizure associated with its use, clozaril should be used only in patients who have failed to respond adequately to standard antipsychotic treatment . [see warnings and precautions (5.1, 5.4)] the effectiveness of clozaril in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozaril and chlorpromazine in patients who had failed other antipsychotics . [see clinical studies (14.1)] clozaril is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to action

Solantel 200 mg/ml Pour-On Solution for Cattle Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

solantel 200 mg/ml pour-on solution for cattle

norbrook laboratories (ireland) limited - closantel sodium dihydrate - pour-on solution - 200 milligram(s)/millilitre - closantel

Solantel 50 mg/ml Oral Suspension for Sheep Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

solantel 50 mg/ml oral suspension for sheep

norbrook laboratories (ireland) limited - closantel sodium dihydrate - oral suspension - 50 milligram(s)/millilitre - closantel

VIRBAC CLOSICARE SUSTAINED ACTION ORAL ANTHELMINTIC AND FLUKICIDE FOR SHEEP Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac closicare sustained action oral anthelmintic and flukicide for sheep

virbac (australia) pty ltd - closantel - oral solution/suspension - closantel anthelmintic active 37.5 g/l - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm-haemonchus contortus | liver fluke - mature and immature | nasal bot | liver fluke-6 week old stages | sheep nasal bot fly

SEPONVER SE SUSTAINED ACTION ORAL ANTHELMINTIC AND FLUKICIDE FOR SHEEP WITH SELENIUM Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

seponver se sustained action oral anthelmintic and flukicide for sheep with selenium

intervet australia pty limited - closantel; selenium - oral solution/suspension - closantel anthelmintic active 37.5 g/l; selenium mineral-selenium active 0.5 g/l - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm-haemonchus contortus | liver fluke | nasal bot | selenium responsive condition | correct selenium responsive co | prevent selenium responsive co | sheep nasal bot fly

Clozaril Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

clozaril

viatris limited - clozapine 100mg;  ;  ;   - tablet - 100 mg - active: clozapine 100mg       excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone purified talc purified water - clozaril is indicated in patients with treatment-resistant schizophrenia, i.e. patients with schizophrenia who are non-responsive to or intolerant of classic antipsychotics. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two marketed antipsychotics prescribed for adequate durations. intolerance is defined as the impossibility of achieving adequate clinical benefit with classic antipsychotics because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).